Wang X, Liu M, Zhang L, Ma K. Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Poor Prognosis in Small-cell Lung Cancer. Arch Med Res 2016;47(1):19-24.
DOI: 10.1016/j.arcmed.2015.12.006
Soomro Z, Youssef M, Yust-Katz S, et al. Paraneoplastic syndromes in small cell lung cancer. J Thorac Dis. 2020;12(10):6253-63.
DOI: 10.21037/jtd.2020.03.88
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65(2):87-108.
DOI: 10.3322/caac.21262
Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet 2017;389(10066):299-311.
DOI: 10.1016/S0140-6736(16)30958-8
Odell WD. Endocrine/metabolic syndromes of cancer. Semin Oncol 1997;24(3):299-317.
Ochoa-Carrillo F, Chávez-Mac Gregor M, Green-Renner D, et al. Síndromes paraneoplásicos Su asociación con el carcinoma pulmonar. Cir Ciruj 2003;71:150-61.
Yasir M, Mechanic OJ. Syndrome of Inappropriate Antidiuretic Hormone Secretion. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
Refardt J. Diagnosis and differential diagnosis of diabetes insipidus: Update. Best Pract Res Clin Endocrinol Metab 2020;34(5):101398.
DOI: 10.1016/j.beem.2020.101398
Christ-Crain M, Refardt J, Winzeler B. Approach to the Patient: "Utility of the Copeptin Assay". J Clin Endocrinol Metab 2022;107(6):1727-38.
DOI: 10.1210/clinem/dgac070